Please Wait

Applying Filters...

CDMO Activity Tracker: Axplora enhances ADC capacities, Quotient beefs up HPAPI capabilities; Evonik, EUROAPI forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

Cefuroxime Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 13 USDMF, 14 CEP/COS, 6 EU WC, 1 KDMF, 1 NDC API, 10 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

215 FDF Dossiers, 35 FDA Orange Book, 70 Europe, 2 Canada, 8 Australia, 52 South Africa, 48 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 7.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 750MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 30MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 Actylis, 1 Kerry, 1 Microlex e.U, 1 Pluviaendo, 1 Roquette

EXCIPIENTS BY APPLICATIONS

2 Parenteral, 2 Fillers, Diluents & Binders, 1 Taste Masking, 1 Co-Processed Excipients

DIGITAL CONTENT

1 News #PharmaBuzz

1 News #PharmaBuzz

GLOBAL SALES INFORMATION

35 Regulatory FDF Prices

35 Regulatory FDF Prices

MARKET PLACE

12 APIs, 5 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	ACS DOBFAR SPA	Italy	ACS DOBFAR SPA	13205	CEFUROXIME SODIUM (STERILE BULK)	1998-04-30	Active	II	N/A
28/03/2025	Aurobindo Pharma Limited	India	AUROBINDO PHARMA LTD	18530	CEFUROXIME SODIUM	2005-07-15	Inactive	II	N/A

Contact us
to update this info

Cefuroxime Sodium

Cefuroxime Sodium

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers

13 USDMF

14 CEP/COS

6 EU WC

1 KDMF

1 NDC API

10 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

215 FDF Dossiers

35 FDA Orange Book

70 Europe

2 Canada

8 Australia

52 South Africa

48 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 7.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 750MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 30MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 Actylis

1 Kerry

1 Microlex e.U

1 Pluviaendo

1 Roquette

EXCIPIENTS BY APPLICATIONS

2 Parenteral

2 Fillers, Diluents & Binders

1 Taste Masking

1 Co-Processed Excipients

DIGITAL CONTENT

1 News #PharmaBuzz

GLOBAL SALES INFORMATION

35 Regulatory FDF Prices

MARKET PLACE

12 APIs

5 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM

1 USP

1 Others

ANALYTICAL

1 BioAnalytical Methods

Filters

INJECTABLE;INJECTION - EQ 1.5GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 7.5GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 750MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons